Home HIV	FAQ My Amedeo About	Flying Publisher
	Amedeo Prize 2008 The 21 Finalists

Peptic Ulcer

Free Subscription Articles published in Aliment Pharmacol Ther Retrieve available abstracts of 167 articles: HTML format

Single Articles

April 2008
1. HUNT RH , Armstrong D, Yaghoobi M, James C, et al
   Predictable prolonged suppression of gastric acidity with a novel proton pump inhibitor, AGN 201904-Z.
   Aliment Pharmacol Ther. 2008;.
   PubMed     Related articles    Abstract available
   
   
   March 2008
2. DE JONGE PJ , Siersema PD, van Breda SG, van Zoest KP, et al
   Proton pump inhibitor therapy in gastro-oesophageal reflux disease decreases the oesophageal immune response but does not reduce the formation of DNA adducts.
   Aliment Pharmacol Ther. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
3. SOEST EM , Dieleman JP, Sturkenboom MC, Siersema PD, et al
   Gastro-oesophageal reflux, medical resource utilisation and upper gastrointestinal endoscopy in patients at risk of oesophageal adenocarcinoma.
   Aliment Pharmacol Ther. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
4. PACE F , Pallotta S, Tonini M, Vakil N, et al
   Systematic review; gastroesophageal reflux disease and dental lesions.
   Aliment Pharmacol Ther. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
5. CHASSANY O , Holtmann G, Malagelada J, Gebauer U, et al
   Systematic Review: A Systematic Review of Health-Related Quality of Life (HRQOL) Questionnaires in Gastroesophageal Reflux Disease (GERD).
   Aliment Pharmacol Ther. 2008;.
   PubMed     Related articles    Abstract available
   
   
   February 2008
6. WAHLQVIST P , Karlsson M, Johnson D, Carlsson J, et al
   Relationship between symptom load of gastroesophageal reflux disease and health-related quality of life, work productivity, resource utilization and concomitant diseases: survey of a US cohort.
   Aliment Pharmacol Ther. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
7. HIRSCHOWITZ BI , Worthington J, Mohnen J
   Vitamin b12 deficiency in hypersecretors during long-term acid suppression with proton-pump inhibitors.
   Aliment Pharmacol Ther. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
8. RUBIN G , Uebel P, Brimo-Hayek A, Hey KH, et al
   Validation of a brief symptom questionnaire (ReQuest in Practice(trade mark)) for patients with gastroesophageal reflux disease (GERD).
   Aliment Pharmacol Ther. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
9. GLUUD LL , Klingenberg SL, Langholz SE
   Tranexamic acid for upper gastrointestinal bleeding: systematic review of randomised trials.
   Aliment Pharmacol Ther. 2008;.
   PubMed     Related articles    Abstract available
   
   
   January 2008
10. SUNG JJ , Mossner J, Barkun A, Kuipers EJ, et al
    Intravenous esomeprazole for prevention of peptic ulcer re-bleeding: rationale/design of the Peptic Ulcer Bleed study.
    Aliment Pharmacol Ther. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
11. GALMICHE JP , Zerbib F, Bruley des Varannes S
    Review article: respiratory manifestations of gastro-oesophageal reflux disease (GORD).
    Aliment Pharmacol Ther. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
12. NOJKOV B , Rubenstein J, Adlis S, Shaw M, et al
    Predictors of response to proton pump inhibitor therapy in patients with gastroesophageal reflux disease: the impact of co-morbidities on treatment outcomes and quality of life.
    Aliment Pharmacol Ther. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
13. DEN ELZEN WP , Groeneveld Y, De Ruijter W, Souverijn JH, et al
    Long-term use of proton pump inhibitors (PPIs) and vitamin B12 status in elderly individuals.
    Aliment Pharmacol Ther. 2008;.
    PubMed     Related articles    Abstract available
    
    
    December 2007
14. PISEGNA JR , Sostek MB, Monyak JT, Miner PB Jr, et al
    Intravenous esomeprazole 40 mg vs. intravenous lansoprazole 30 mg in controlling intragastric acidity in healthy adults.
    Aliment Pharmacol Ther. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
15. DE VRIES AC , Kuipers EJ
    Review article: Helicobacter pylori eradication for the prevention of gastric cancer.
    Aliment Pharmacol Ther. 2007;26 Suppl 2:25-35.
    PubMed     Related articles    Abstract available
    
    
    
16. OUDKERK POOL M
    Review article: Gastro-oesophageal reflux disease--application of the concept of complete remission.
    Aliment Pharmacol Ther. 2007;26 Suppl 2:13-6.
    PubMed     Related articles    Abstract available
    
    
    
17. SMOUT AJ
    Review article: The measurement of non-acid gastro-oesophageal reflux.
    Aliment Pharmacol Ther. 2007;26 Suppl 2:7-12.
    PubMed     Related articles    Abstract available
    
    
    
18. SCHWARTZ MP , Smout AJ
    Review article: The endoscopic treatment of gastro-oesophageal reflux disease.
    Aliment Pharmacol Ther. 2007;26 Suppl 2:1-6.
    PubMed     Related articles    Abstract available
    
    
    November 2007
19. HILLMAN LC , Chiragakis L, Shadbolt B, Kaye GL, et al
    Effect of proton pump inhibitors on markers of risk for high grade dysplasia and oesophageal cancer in Barrett's oesophagus.
    Aliment Pharmacol Ther. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
20. DEAN BB , Aguilar D, Johnson LF, McGuigan JE, et al
    Nighttime and daytime atypical manifestations of gastroesophageal reflux disease: frequency, severity, and impact on health-related quality of life.
    Aliment Pharmacol Ther. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
21. FORD AC , Forman D, Nathan J, Crocombe WD, et al
    Clinical trial: knowledge of negative Helicobacter pylori status reduces subsequent dyspepsia-related resource use.
    Aliment Pharmacol Ther. 2007;26:1267-75.
    PubMed     Related articles    Abstract available
    
    
    
22. JANIAK P , Thumshirn M, Menne D, Fox M, et al
    Clinical trial: the effects of adding ranitidine at night to twice daily omeprazole therapy on nocturnal acid breakthrough and acid reflux in patients with systemic sclerosis - a randomized controlled, cross-over trial.
    Aliment Pharmacol Ther. 2007;26:1259-65.
    PubMed     Related articles    Abstract available
    
    
    October 2007
23. TYTGAT GN , McColl K, Tack J, Holtmann G, et al
    New algorithm for the treatment of gastroesophageal reflux disease.
    Aliment Pharmacol Ther. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
24. TAHA AS , Angerson WJ, Prasad R, McCloskey C, et al
    Upper gastrointestinal bleeding and the changing use of COX-2 non-steroidal anti-inflammatory drugs and low-dose aspirin.
    Aliment Pharmacol Ther. 2007;26:1171-8.
    PubMed     Related articles    Abstract available
    
    
    
25. GOLDSTEIN JL , Johanson JF, Hawkey CJ, Suchower LJ, et al
    Clinical trial: healing of NSAID-associated gastric ulcers in patients continuing NSAID therapy - a randomized study comparing ranitidine with esomeprazole.
    Aliment Pharmacol Ther. 2007;26:1101-11.
    PubMed     Related articles    Abstract available
    
    
    
26. JANSSON C , Nordenstedt H, Wallander MA, Johansson S, et al
    Severe symptoms of gastro-oesophageal reflux disease are associated with cardiovascular disease and other gastrointestinal symptoms, but not diabetes: a population-based study.
    Aliment Pharmacol Ther. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
27. MOKI F , Kusano M, Mizuide M, Shimoyama Y, et al
    Association between reflux oesophagitis and features of the metabolic syndrome in Japan.
    Aliment Pharmacol Ther. 2007;26:1069-75.
    PubMed     Related articles    Abstract available
    
    
    
28. YEE YK , Cheung TK, Chu KM, Chan CK, et al
    Clinical trial: levofloxacin-based quadruple therapy was inferior to traditional quadruple therapy in the treatment of resistant Helicobacter pylori infection.
    Aliment Pharmacol Ther. 2007;26:1063-7.
    PubMed     Related articles    Abstract available
    
    
    
29. SINGH M , Dhindsa G, Friedland S, Triadafilopoulos G, et al
    Long-term use of proton pump inhibitors does not affect the frequency, growth, or histologic characteristics of colon adenomas.
    Aliment Pharmacol Ther. 2007;26:1051-61.
    PubMed     Related articles    Abstract available
    
    
    September 2007
30. VAN DER POORTEN D , Katelaris PH
    The effectiveness of rifabutin triple therapy for difficult to eradicate Helicobacter pylori in clinical practice.
    Aliment Pharmacol Ther. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
31. BECKER V , Bajbouj M, Waller K, Schmid RM, et al
    Clinical Trial: persistent gastroesophageal reflux symptoms despite standard therapy with proton pump inhibitors - a follow-up study of intraluminal-impedance guided therapy.
    Aliment Pharmacol Ther. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
32. FORNARI F , Blondeau K, Durand L, Rey E, et al
    Relevance of mild ineffective oesophageal motility (IOM) and potential pharmacological reversibility of severe IOM in patients with gastro-oesophageal reflux disease.
    Aliment Pharmacol Ther. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
33. TSENG GY , Lin HJ, Fang CT, Yang HB, et al
    Recurrence of peptic ulcer in uraemic and non-uraemic patients after Helicobacter pylori eradication: a 2-year study.
    Aliment Pharmacol Ther. 2007;26:925-33.
    PubMed     Related articles    Abstract available
    
    
    
34. BROOK RA , Wahlqvist P, Kleinman NL, Wallander MA, et al
    Cost of gastro-oesophageal reflux disease to the employer: a perspective from the United States.
    Aliment Pharmacol Ther. 2007;26:889-98.
    PubMed     Related articles    Abstract available
    
    
    
35. HIRSCHOWITZ BI , Worthington J, Mohnen J, Haber M, et al
    Chromogranin A in patients with acid hypersecretion and/or hypergastrinaemia.
    Aliment Pharmacol Ther. 2007;26:869-78.
    PubMed     Related articles    Abstract available
    
    
    
36. FURUTA T , Sugimoto M, Shirai N, Matsushita F, et al
    Effect of MDR1 C3435T polymorphism on cure rates of Helicobacter pylori infection by triple therapy with lansoprazole, amoxicillin and clarithromycin in relation to CYP 2C19 genotypes and 23S rRNA genotypes of H. pylori.
    Aliment Pharmacol Ther. 2007;26:693-703.
    PubMed     Related articles    Abstract available
    
    
    
37. JANSSON C , Nordenstedt H, Wallander MA, Johansson S, et al
    Severe gastro-oesophageal reflux symptoms in relation to anxiety, depression and coping in a population-based study.
    Aliment Pharmacol Ther. 2007;26:683-91.
    PubMed     Related articles    Abstract available
    
    
    
38. TALLEY NJ , Vakil N, Lauritsen K, VAN Zanten SV, et al
    Randomized-controlled trial of esomeprazole in functional dyspepsia patients with epigastric pain or burning: does a 1-week trial of acid suppression predict symptom response?
    Aliment Pharmacol Ther. 2007;26:673-82.
    PubMed     Related articles    Abstract available
    
    
    
39. VAN ZANTEN SV , Flook N, Talley NJ, Vakil N, et al
    One-week acid suppression trial in uninvestigated dyspepsia patients with epigastric pain or burning to predict response to 8 weeks' treatment with esomeprazole: a randomized, placebo-controlled study.
    Aliment Pharmacol Ther. 2007;26:665-72.
    PubMed     Related articles    Abstract available
    
    
    August 2007
40. SIERRA F , Suarez M, Rey M, Vela MF, et al
    Systematic review: proton pump inhibitor-associated acute interstitial nephritis.
    Aliment Pharmacol Ther. 2007;26:545-53.
    PubMed     Related articles    Abstract available
    
    
    
41. GISBERT JP , Fernandez-Bermejo M, Molina-Infante J, Perez-Gallardo B, et al
    First-line triple therapy with levofloxacin for Helicobacter pylori eradication.
    Aliment Pharmacol Ther. 2007;26:495-500.
    PubMed     Related articles    Abstract available
    
    
    
42. JUNG HK , Halder S, McNally M, Locke Iii GR, et al
    Overlap of gastro-oesophageal reflux disease and irritable bowel syndrome: prevalence and risk factors in the general population.
    Aliment Pharmacol Ther. 2007;26:453-61.
    PubMed     Related articles    Abstract available
    
    
    
43. FISCHBACH L , Evans EL
    Meta-analysis: the effect of antibiotic resistance status on the efficacy of triple and quadruple first-line therapies for Helicobacter pylori.
    Aliment Pharmacol Ther. 2007;26:343-57.
    PubMed     Related articles    Abstract available
    
    
    
44. ANAGNOSTOPOULOS GK , Yao K, Kaye P, Hawkey CJ, et al
    Novel endoscopic observation in Barrett's oesophagus using high resolution magnification endoscopy and narrow band imaging.
    Aliment Pharmacol Ther. 2007;26:501-7.
    PubMed     Related articles    Abstract available
    
    
    July 2007
45. VAN SOEST EM , Sturkenboom MC, Dieleman JP, Verhamme KM, et al
    Adherence to gastroprotection and the risk of NSAID-related upper gastrointestinal ulcers and haemorrhage.
    Aliment Pharmacol Ther. 2007;26:265-75.
    PubMed     Related articles    Abstract available
    
    
    
46. HOGAN D , Pratha V, Riff D, Ducker S, et al
    Oral pantoprazole in the form of granules or tablets are pharmacodynamically equivalent in suppressing acid output in patients with gastro-oesophageal reflux disease and a history of erosive oesophagitis.
    Aliment Pharmacol Ther. 2007;26:249-56.
    PubMed     Related articles    Abstract available
    
    
    
47. BOECKXSTAENS GE
    Review article: the pathophysiology of gastro-oesophageal reflux disease.
    Aliment Pharmacol Ther. 2007;26:149-60.
    PubMed     Related articles    Abstract available
    
    
    
48. MIWA H , Sasaki M, Furuta T, Koike T, et al
    Efficacy of rabeprazole on heartburn symptom resolution in patients with non-erosive and erosive gastro-oesophageal reflux disease: a multicenter study from Japan.
    Aliment Pharmacol Ther. 2007;26:69-77.
    PubMed     Related articles    Abstract available
    
    
    
49. CONCHILLO JM , Schwartz MP, Selimah M, Samsom M, et al
    Role of intra-oesophageal impedance monitoring in the evaluation of endoscopic gastroplication for gastro-oesophageal reflux disease.
    Aliment Pharmacol Ther. 2007;26:61-8.
    PubMed     Related articles    Abstract available
    
    
    
50. DICKMAN R , Parthasarathy S, Malagon IB, Jones P, et al
    Comparisons of the distribution of oesophageal acid exposure throughout the sleep period among the different gastro-oesophageal reflux disease groups.
    Aliment Pharmacol Ther. 2007;26:41-8.
    PubMed     Related articles    Abstract available
    
    
    
51. PACE F , Tonini M, Pallotta S, Molteni P, et al
    Systematic review: maintenance treatment of gastro-oesophageal reflux disease with proton pump inhibitors taken 'on-demand'
    Aliment Pharmacol Ther. 2007;26:195-204.
    PubMed     Related articles    Abstract available
    
    
    June 2007
52. BARDHAN KD , Achim A, Riddermann T, Pfaffenberger B, et al
    A clinical trial comparing pantoprazole and esomeprazole to explore the concept of achieving 'complete remission' in gastro-oesophageal reflux disease.
    Aliment Pharmacol Ther. 2007;25:1461-9.
    PubMed     Related articles    Abstract available
    
    
    
53. MANUEL D , Cutler A, Goldstein J, Fennerty MB, et al
    Decreasing prevalence combined with increasing eradication of Helicobacter pylori infection in the United States has not resulted in fewer hospital admissions for peptic ulcer disease-related complications.
    Aliment Pharmacol Ther. 2007;25:1423-7.
    PubMed     Related articles    Abstract available
    
    
    
54. VAKIL N
    Review article: the role of surgery in gastro-oesophageal reflux disease.
    Aliment Pharmacol Ther. 2007;25:1365-72.
    PubMed     Related articles    Abstract available
    
    
    
55. JONES R , Coyne K, Wiklund I
    The Gastro-oesophageal Reflux Disease Impact Scale: a patient management tool for primary care.
    Aliment Pharmacol Ther. 2007;25:1451-1459.
    PubMed     Related articles    Abstract available
    
    
    
56. ZULLO A , Perna F, Hassan C, Ricci C, et al
    Primary antibiotic resistance in Helicobacter pylori strains isolated in northern and central Italy.
    Aliment Pharmacol Ther. 2007;25:1429-1434.
    PubMed     Related articles    Abstract available
    
    
    
57. LEMBO A , Zaman M, Jones M, Talley NJ, et al
    Influence of genetics on irritable bowel syndrome, gastro-oesophageal reflux and dyspepsia: a twin study.
    Aliment Pharmacol Ther. 2007;25:1343-50.
    PubMed     Related articles    Abstract available
    
    
    May 2007
58. MUNK EM , Drewes AM, Gorst-Rasmussen A, Gregersen H, et al
    Risk of peptic ulcer, oesophagitis, pancreatitis or gallstone in patients with unexplained chest/epigastric pain and normal upper endoscopy: a 10-year Danish cohort study.
    Aliment Pharmacol Ther. 2007;25:1203-10.
    PubMed     Related articles    Abstract available
    
    
    
59. KUWAYAMA H , Asaka M, Sugiyama T, Fukuda Y, et al
    Rabeprazole-based eradication therapy for Helicobacter pylori: a large-scale study in Japan.
    Aliment Pharmacol Ther. 2007;25:1105-13.
    PubMed     Related articles    Abstract available
    
    
    April 2007
60. CHRISTENSEN S , Riis A, Norgaard M, Thomsen RW, et al
    Introduction of newer selective cyclo-oxygenase-2 inhibitors and rates of hospitalization with bleeding and perforated peptic ulcer.
    Aliment Pharmacol Ther. 2007;25:907-12.
    PubMed     Related articles    Abstract available
    
    
    March 2007
61. COTE GA , Ferreira MR, Rozenberg-Ben-Dror K, Howden CW, et al
    Programme of stepping down from twice daily proton pump inhibitor therapy for symptomatic gastro-oesophageal reflux disease associated with a formulary change at a VA medical center.
    Aliment Pharmacol Ther. 2007;25:709-14.
    PubMed     Related articles    Abstract available
    
    
    
62. KATZ PO , Ginsberg GG, Hoyle PE, Sostek MB, et al
    Relationship between intragastric acid control and healing status in the treatment of moderate to severe erosive oesophagitis.
    Aliment Pharmacol Ther. 2007;25:617-28.
    PubMed     Related articles    Abstract available
    
    
    January 2007
63. KATZ PO , Koch FK, Ballard ED, Bagin RG, et al
    Comparison of the effects of immediate-release omeprazole oral suspension, delayed-release lansoprazole capsules and delayed-release esomeprazole capsules on nocturnal gastric acidity after bedtime dosing in patients with night-time GERD symptoms.
    Aliment Pharmacol Ther. 2007;25:197-205.
    PubMed     Related articles    Abstract available
    
    
    
64. TONG JL , Ran ZH, Shen J, Zhang CX, et al
    Meta-analysis: the effect of supplementation with probiotics on eradication rates and adverse events during Helicobacter pylori eradication therapy.
    Aliment Pharmacol Ther. 2007;25:155-68.
    PubMed     Related articles    Abstract available
    
    
    
65. FUCCIO L , Zagari RM, Minardi ME, Bazzoli F, et al
    Systematic review: Helicobacter pylori eradication for the prevention of gastric cancer.
    Aliment Pharmacol Ther. 2007;25:133-41.
    PubMed     Related articles    Abstract available
    
    
    
66. TRAN T , Lowry AM, El-Serag HB
    Meta-analysis: the efficacy of over-the-counter gastro-oesophageal reflux disease therapies.
    Aliment Pharmacol Ther. 2007;25:143-53.
    PubMed     Related articles    Abstract available
    
    
    
67. MINER PB JR , Allgood LD, Grender JM
    Comparison of gastric pH with omeprazole magnesium 20.6 mg (Prilosec OTC) o.m. famotidine 10 mg (Pepcid AC) b.d. and famotidine 20 mg b.d. over 14 days of treatment.
    Aliment Pharmacol Ther. 2007;25:103-9.
    PubMed     Related articles    Abstract available
    
    
    
68. HUNFELD NG , Geus WP, Kuipers EJ
    Systematic review: Rebound acid hypersecretion after therapy with proton pump inhibitors.
    Aliment Pharmacol Ther. 2007;25:39-46.
    PubMed     Related articles    Abstract available
    
    
    
69. SHAPIRO M , Green C, Bautista JM, Dekel R, et al
    Assessment of dietary nutrients that influence perception of intra-oesophageal acid reflux events in patients with gastro-oesophageal reflux disease.
    Aliment Pharmacol Ther. 2007;25:93-101.
    PubMed     Related articles    Abstract available
    
    
    
70. STOLTEY J , Reeba H, Ullah N, Sabhaie P, et al
    Does Barrett's oesophagus develop over time in patients with chronic gastro-oesophageal reflux disease?
    Aliment Pharmacol Ther. 2007;25:83-91.
    PubMed     Related articles    Abstract available
    
    
    December 2006
71. YOSHIDA M , Saikawa Y, Hosoda S, Kumai K, et al
    Endoscopic classifications as diagnostic factors of peptic ulcer and early gastric cancer - a possible reason why Helicobacter pylori infection causes gastric ulcers along lesser curvature.
    Aliment Pharmacol Ther. 2006;24 Suppl 4:303-10.
    PubMed     Related articles    Abstract available
    
    
    
72. NAKAMURA T , Yoshida M, Otani Y, Kameyama K, et al
    Twelve years' progress in surgery for perforated gastric and duodenal ulcers: a retrospective study of indications for laparoscopic surgery, post-operative course and the influence of Candida infection.
    Aliment Pharmacol Ther. 2006;24 Suppl 4:297-302.
    PubMed     Related articles    Abstract available
    
    
    
73. KATO S , Matsukura N, Matsuda N, Tsukada K, et al
    Helicobacter pylori eradication therapy modulates acidity and interleukin-1beta mRNA levels in un-operated stomach and in remnant stomach after gastrectomy in gastric cancer patients.
    Aliment Pharmacol Ther. 2006;24 Suppl 4:278-84.
    PubMed     Related articles    Abstract available
    
    
    
74. TANAKA J , Ohkusa T, Yokoyama T, Matsuhisa T, et al
    Host serological response to Helicobacter pylori after successful eradication: long-term follow-up in patients with cured and persistent infection.
    Aliment Pharmacol Ther. 2006;24 Suppl 4:239-48.
    PubMed     Related articles    Abstract available
    
    
    
75. NAKAGAWA S , Asaka M, Kato M, Nakamura T, et al
    Helicobacter pylori eradication and metachronous gastric cancer after endoscopic mucosal resection of early gastric cancer.
    Aliment Pharmacol Ther. 2006;24 Suppl 4:214-8.
    PubMed     Related articles    Abstract available
    
    
    
76. NAKAMURA M , Matsui H, Serizawa H, Murayama SY, et al
    Coinfection of Helicobacter pylori and Neisseria subflava is closely associated with lymph follicle formation in human stomach.
    Aliment Pharmacol Ther. 2006;24 Suppl 4:207-13.
    PubMed     Related articles    Abstract available
    
    
    
77. KATO M , Asaka M, Nakamura T, Azuma T, et al
    Helicobacter pylori eradication prevents the development of gastric cancer - results of a long-term retrospective study in Japan.
    Aliment Pharmacol Ther. 2006;24 Suppl 4:203-6.
    PubMed     Related articles    Abstract available
    
    
    
78. TANAKA A , Watari J, Tanabe H, Maemoto A, et al
    Effect of eradication of Helicobacter pylori on genetic instabilities in gastric intestinal metaplasia.
    Aliment Pharmacol Ther. 2006;24 Suppl 4:194-202.
    PubMed     Related articles    Abstract available
    
    
    
79. MORIYAMA T , Kaneko T, Fujii M, Tsubakihara Y, et al
    High prevalence of Helicobacter pylori infection in Japanese patients with membranous nephropathy.
    Aliment Pharmacol Ther. 2006;24 Suppl 4:189-93.
    PubMed     Related articles    Abstract available
    
    
    
80. SUZUKI M , Tanaka S, Komatsu H, Nakane T, et al
    Evaluation of alcohol metabolism in humans using the non-invasive [C]-ethanol breath test - influence of gender, Helicobacter pylori infection and polymorphism of alcohol-oxidizing enzymes.
    Aliment Pharmacol Ther. 2006;24 Suppl 4:177-81.
    PubMed     Related articles    Abstract available
    
    
    
81. PLONKA M , Konturek PC, Bielanski W, Pawlik T, et al
    Relationship between ghrelin and Helicobacter pylori infection in Polish adult shepherds and their children.
    Aliment Pharmacol Ther. 2006;24 Suppl 4:160-8.
    PubMed     Related articles    Abstract available
    
    
    
82. DEGUCHI R , Watanabe K, Koga Y, Kijima H, et al
    Interaction between Helicobacter pylori and immune response to CagA: CagA antibody may down-regulate bacterial colonization and tyrosine phosphorylation.
    Aliment Pharmacol Ther. 2006;24 Suppl 4:127-31.
    PubMed     Related articles    Abstract available
    
    
    
83. OHARA T , Kasanuki J, Morishita T, Yamamoto N, et al
    Evaluation of the role of Helicobacter pylori as a promoter of gastric cancer from the viewpoint of structural chromosomal aberration.
    Aliment Pharmacol Ther. 2006;24 Suppl 4:111-9.
    PubMed     Related articles    Abstract available
    
    
    
84. MASAOKA T , Suzuki H, Kurabayashi K, Nomoto Y, et al
    Could frameshift mutations in the frxA and rdxA genes of Helicobacter pylori be a marker for metronidazole resistance?
    Aliment Pharmacol Ther. 2006;24 Suppl 4:81-7.
    PubMed     Related articles    Abstract available
    
    
    
85. SHIOTANI A , Iishi H, Uedo N, Ishihara R, et al
    Helicobacter pylori-induced atrophic gastritis progressing to gastric cancer exhibits sonic hedgehog loss and aberrant CDX2 expression.
    Aliment Pharmacol Ther. 2006;24 Suppl 4:71-80.
    PubMed     Related articles    Abstract available
    
    
    
86. ANDO T , Minami M, Ishiguro K, Maeda O, et al
    Changes in biochemical parameters related to atherosclerosis after Helicobacter pylori eradication.
    Aliment Pharmacol Ther. 2006;24 Suppl 4:58-64.
    PubMed     Related articles    Abstract available
    
    
    
87. KADOUCHI K , Tominaga K, Ochi M, Kawamura E, et al
    Interactions between the grading of gastric atrophy associated with Helicobacter pylori infection and the severity of clinical symptoms and delay in gastric emptying in patients with functional dyspepsia.
    Aliment Pharmacol Ther. 2006;24 Suppl 4:49-57.
    PubMed     Related articles    Abstract available
    
    
    
88. AMANO Y , Chinuki D, Yuki T, Takahashi Y, et al
    Efficacy of proton pump inhibitors for cellular proliferation and apoptosis in Barrett's oesophagus with different mucin phenotypes.
    Aliment Pharmacol Ther. 2006;24 Suppl 4:41-8.
    PubMed     Related articles    Abstract available
    
    
    
89. KAWAI T , Kawakami K, Kataoka M, Takei K, et al
    Correlation of serum pepsinogen with histological atrophy following successful Helicobacter pylori eradication.
    Aliment Pharmacol Ther. 2006;24 Suppl 4:23-30.
    PubMed     Related articles    Abstract available
    
    
    
90. KAWAI T , Kawakami K, Kataoka M, Taira S, et al
    Comparison of efficacies of dual therapy and triple therapy using rabeprazole in second-line eradication of Helicobacter pylori in Japan.
    Aliment Pharmacol Ther. 2006;24 Suppl 4:16-22.
    PubMed     Related articles    Abstract available
    
    
    
91. FUTAGAMI S , Hiratsuka T, Shindo T, Hamamoto T, et al
    Helicobacter pylori infection induces accumulation of Vdelta1 T cells via CCR2 upregulation.
    Aliment Pharmacol Ther. 2006;24 Suppl 4:8-15.
    PubMed     Related articles    Abstract available
    
    
    
92. DEVLIN JW , Bakshi A, Bungay K, Olsen KM, et al
    An in vitro comparison of different providers to deliver four proton pump inhibitor products through a feeding tube.
    Aliment Pharmacol Ther. 2006;24.
    PubMed     Related articles    Abstract available
    
    
    
93. MARIE I , Ducrotte P, Denis P, Hellot MF, et al
    Oesophageal mucosal involvement in patients with systemic sclerosis receiving proton pump inhibitor therapy.
    Aliment Pharmacol Ther. 2006;24.
    PubMed     Related articles    Abstract available
    
    
    
94. IWAMOTO M , Kato K, Mizuno S, Miyamoto S, et al
    Evaluation of gastro-oesophageal flap valve is useful for diagnosing gastro-oesophageal reflux disease.
    Aliment Pharmacol Ther. 2006;24 Suppl 4:141-6.
    PubMed     Related articles    Abstract available
    
    
    
95. SUZUKI H , Masaoka T, Nomoto Y, Hosoda H, et al
    Increased levels of plasma ghrelin in peptic ulcer disease.
    Aliment Pharmacol Ther. 2006;24 Suppl 4:120-6.
    PubMed     Related articles    Abstract available
    
    
    November 2006
96. ARMSTRONG D , James C, Camacho F, Chen Y, et al
    Oral rabeprazole vs. intravenous pantoprazole: a comparison of the effect on intragastric pH in healthy subjects.
    Aliment Pharmacol Ther. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
97. BATESON MC
    Excellent therapy for Helicobacter pylori infection.
    Aliment Pharmacol Ther. 2006;24:1505.
    PubMed     Related articles   
    
    
    
98. MOROCUTTI A , Merrouche M, Bjaaland T, Humphries T, et al
    An open-label study of rabeprazole in patients with Zollinger-Ellison syndrome or idiopathic gastric acid hypersecretion.
    Aliment Pharmacol Ther. 2006;24:1439-44.
    PubMed     Related articles    Abstract available
    
    
    
99. AANEN MC , Weusten BL, Numans ME, DE Wit NJ, et al
    Diagnostic value of the proton pump inhibitor test for gastro-oesophageal reflux disease in primary care.
    Aliment Pharmacol Ther. 2006;24:1377-84.
    PubMed     Related articles    Abstract available
    
    
    
100. JOHN ALBERT M , Al-Mekhaizeem K, Neil L, Dhar R, et al
     High prevalence and level of resistance to metronidazole, but lack of resistance to other antimicrobials in Helicobacter pylori, isolated from a multiracial population in Kuwait.
     Aliment Pharmacol Ther. 2006;24:1359-66.
     PubMed     Related articles    Abstract available
     
     
     
101. JALVING M , Koornstra JJ, Wesseling J, Boezen HM, et al
     Increased risk of fundic gland polyps during long-term proton pump inhibitor therapy.
     Aliment Pharmacol Ther. 2006;24:1341-8.
     PubMed     Related articles    Abstract available
     
     
     
102. DENT J
     Review article: from 1906 to 2006 - a century of major evolution of understanding of gastro-oesophageal reflux disease.
     Aliment Pharmacol Ther. 2006;24:1269-81.
     PubMed     Related articles    Abstract available
     
     
     October 2006
103. MATSUO K , Suzuki T, Tajima K
     CagA status and successful eradication of Helicobacter pylori: authors' reply.
     Aliment Pharmacol Ther. 2006;24:1263.
     PubMed     Related articles   
     
     
     
104. TREIBER G , Malfertheiner P
     CagA status and successful eradication of Helicobacter pylori.
     Aliment Pharmacol Ther. 2006;24:1261-3.
     PubMed     Related articles   
     
     
     
105. KEYVANI L , Murthy S, Leeson S, Targownik LE, et al
     Pre-endoscopic proton pump inhibitor therapy reduces recurrent adverse gastrointestinal outcomes in patients with acute non-variceal upper gastrointestinal bleeding.
     Aliment Pharmacol Ther. 2006;24:1247-55.
     PubMed     Related articles    Abstract available
     
     
     
106. MIKI M , Adachi K, Azumi T, Koshino K, et al
     A comparative study of intragastric acidity during post-breakfast and pre-dinner administration of low-dose proton pump inhibitors: a randomized three-way crossover study.
     Aliment Pharmacol Ther. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
107. GISBERT JP , Gisbert JL, Marcos S, Moreno-Otero R, et al
     Third-line rescue therapy with levofloxacin is more effective than rifabutin rescue regimen after two Helicobacter pylori treatment failures.
     Aliment Pharmacol Ther. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
108. THOMSEN RW , Riis A, Christensen S, McLaughlin JK, et al
     Outcome of peptic ulcer bleeding among users of traditional non-steroidal anti-inflammatory drugs and selective cyclo-oxygenase-2 inhibitors.
     Aliment Pharmacol Ther. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
109. GRUDELL AB , Camilleri M, Burton DD, Stephens DA, et al
     Effect of a proton pump inhibitor on postprandial gastric volume, emptying and symptoms in healthy human subjects: a pilot study.
     Aliment Pharmacol Ther. 2006;24:1037-43.
     PubMed     Related articles    Abstract available
     
     
     
110. MEINECHE-SCHMIDT V , Hvenegaard A, Juhl HH
     Participation in a clinical trial influences the future management of patients with gastro-oesophageal reflux disease in general practice.
     Aliment Pharmacol Ther. 2006;24:1117-25.
     PubMed     Related articles    Abstract available
     
     
     
111. KIM HS , Conklin JL, Park H
     The effect of sildenafil on segmental oesophageal motility and gastro-oesophageal reflux.
     Aliment Pharmacol Ther. 2006;24:1029-36.
     PubMed     Related articles    Abstract available
     
     
     September 2006
112. BJORNSSON E , Abrahamsson H, Simren M, Mattsson N, et al
     Discontinuation of proton pump inhibitors in patients on long-term therapy: a double-blind, placebo-controlled trial.
     Aliment Pharmacol Ther. 2006;24:945-54.
     PubMed     Related articles    Abstract available
     
     
     
113. GRAHAM DY , Abudayyeh S, El-Zimaity HM, Hoffman J, et al
     Sequential therapy using high-dose esomeprazole-amoxicillin followed by gatifloxacin for Helicobacter pylori infection.
     Aliment Pharmacol Ther. 2006;24:845-50.
     PubMed     Related articles    Abstract available
     
     
     
114. YE BD , Cheon JH, Choi KD, Kim SG, et al
     Omeprazole may be superior to famotidine in the management of iatrogenic ulcer after endoscopic mucosal resection: a prospective randomized controlled trial.
     Aliment Pharmacol Ther. 2006;24:837-43.
     PubMed     Related articles    Abstract available
     
     
     
115. EDWARDS SJ , Lind T, Lundell L
     Systematic review: proton pump inhibitors (PPIs) for the healing of reflux oesophagitis - a comparison of esomeprazole with other PPIs.
     Aliment Pharmacol Ther. 2006;24:743-50.
     PubMed     Related articles    Abstract available
     
     
     
116. TUTUIAN R , Castell DO
     Review article: complete gastro-oesophageal reflux monitoring - combined pH and impedance.
     Aliment Pharmacol Ther. 2006;24 Suppl 2:27-37.
     PubMed     Related articles    Abstract available
     
     
     
117. DE HERTOGH G , Ectors N, VAN Eyken P, Geboes K, et al
     Review article: the nature of oesophageal injury in gastro-oesophageal reflux disease.
     Aliment Pharmacol Ther. 2006;24 Suppl 2:17-26.
     PubMed     Related articles    Abstract available
     
     
     
118. TACK J
     Review article: the role of bile and pepsin in the pathophysiology and treatment of gastro-oesophageal reflux disease.
     Aliment Pharmacol Ther. 2006;24 Suppl 2:10-6.
     PubMed     Related articles    Abstract available
     
     
     
119. ROBERTS NB
     Review article: human pepsins - their multiplicity, function and role in reflux disease.
     Aliment Pharmacol Ther. 2006;24 Suppl 2:2-9.
     PubMed     Related articles    Abstract available
     
     
     
120. BARON JH , Watson F, Sonnenberg A
     Three centuries of stomach symptoms in Scotland.
     Aliment Pharmacol Ther. 2006;24:821-9.
     PubMed     Related articles    Abstract available
     
     
     August 2006
121. CAMERON EA , Bell GD
     Re-infection following successful eradication of Helicobacter pylori infection: authors' reply.
     Aliment Pharmacol Ther. 2006;24:696-8.
     PubMed     Related articles   
     
     
     
122. SAAD RA
     Re-infection following successful eradication of Helicobacter pylori infection.
     Aliment Pharmacol Ther. 2006;24:695-6.
     PubMed     Related articles   
     
     
     
123. KORSTANJE A , van Eeden S, Offerhaus GJ, Sabbe LJ, et al
     The 13carbon urea breath test for the diagnosis of Helicobacter pylori infection in subjects with atrophic gastritis: evaluation in a primary care setting.
     Aliment Pharmacol Ther. 2006;24:643-50.
     PubMed     Related articles    Abstract available
     
     
     
124. BENNETT K , Feely J, Thornton O, Dobson M, et al
     Impact of Helicobacter pylori on the management of dyspepsia in primary care.
     Aliment Pharmacol Ther. 2006;24:637-41.
     PubMed     Related articles    Abstract available
     
     
     
125. YEARSLEY KA , Gilby LJ, Ramadas AV, Kubiak EM, et al
     Proton pump inhibitor therapy is a risk factor for Clostridium difficile-associated diarrhoea.
     Aliment Pharmacol Ther. 2006;24:613-9.
     PubMed     Related articles    Abstract available
     
     
     
126. TAHA AS , Angerson WJ, Knill-Jones RP, Blatchford O, et al
     Clinical outcome in upper gastrointestinal bleeding complicating low-dose aspirin and antithrombotic drugs.
     Aliment Pharmacol Ther. 2006;24:633-6.
     PubMed     Related articles    Abstract available
     
     
     July 2006
127. MIEHLKE S , Hansky K, Schneider-Brachert W, Kirsch C, et al
     Randomized trial of rifabutin-based triple therapy and high-dose dual therapy for rescue treatment of Helicobacter pylori resistant to both metronidazole and clarithromycin.
     Aliment Pharmacol Ther. 2006;24:395-403.
     PubMed     Related articles    Abstract available
     
     
     
128. VAN SOEST EM , Siersema PD, Dieleman JP, Sturkenboom MC, et al
     Persistence and adherence to proton pump inhibitors in daily clinical practice.
     Aliment Pharmacol Ther. 2006;24:377-85.
     PubMed     Related articles    Abstract available
     
     
     
129. SUZUKI T , Matsuo K, Sawaki A, Ito H, et al
     Systematic review and meta-analysis: importance of CagA status for successful eradication of Helicobacter pylori infection.
     Aliment Pharmacol Ther. 2006;24:273-80.
     PubMed     Related articles    Abstract available
     
     
     
130. WAHLQVIST P , Reilly MC, Barkun A
     Systematic review: the impact of gastro-oesophageal reflux disease on work productivity.
     Aliment Pharmacol Ther. 2006;24:259-72.
     PubMed     Related articles    Abstract available
     
     
     
131. TAM YH , Yeung CK, Lee KH
     Seven-day is more effective than 4-day ranitidine bismuth citrate-based triple therapy in eradication of Helicobacter pylori in children: a prospective randomized study.
     Aliment Pharmacol Ther. 2006;24:81-6.
     PubMed     Related articles    Abstract available
     
     
     
132. VAKIL N , Talley NJ, Stolte M, Sundin M, et al
     Patterns of gastritis and the effect of eradicating Helicobacter pylori on gastro-oesophageal reflux disease in Western patients with non-ulcer dyspepsia.
     Aliment Pharmacol Ther. 2006;24:55-63.
     PubMed     Related articles    Abstract available
     
     
     
133. TUTUIAN R , Mainie I, Allan R, Hargreaves K, et al
     Effects of a 5-HT receptor agonist on oesophageal function and gastro-oesophageal reflux: studies using combined impedance-manometry and combined impedance-pH.
     Aliment Pharmacol Ther. 2006;24:155-62.
     PubMed     Related articles    Abstract available
     
     
     
134. KANG JY , Elders A, Majeed A, Maxwell JD, et al
     Recent trends in hospital admissions and mortality rates for peptic ulcer in Scotland 1982-2002.
     Aliment Pharmacol Ther. 2006;24:65-79.
     PubMed     Related articles    Abstract available
     
     
     
135. FULLARD M , Kang JY, Neild P, Poullis A, et al
     Systematic review: does gastro-oesophageal reflux disease progress?
     Aliment Pharmacol Ther. 2006;24:33-45.
     PubMed     Related articles    Abstract available
     
     
     June 2006
136. DOMINGUEZ J , Forne M, Blanco S, Prat C, et al
     Comparison of a monoclonal with a polyclonal antibody-based enzyme immunoassay stool test in diagnosing Helicobacter pylori infection before and after eradication therapy.
     Aliment Pharmacol Ther. 2006;23:1735-40.
     PubMed     Related articles    Abstract available
     
     
     
137. RONKAINEN J , Aro P, Storskrubb T, Lind T, et al
     Gastro-oesophageal reflux symptoms and health-related quality of life in the adult general population--the Kalixanda study.
     Aliment Pharmacol Ther. 2006;23:1725-33.
     PubMed     Related articles    Abstract available
     
     
     
138. SACHS G , Shin JM, Howden CW
     Review article: the clinical pharmacology of proton pump inhibitors.
     Aliment Pharmacol Ther. 2006;23 Suppl 2:2-8.
     PubMed     Related articles    Abstract available
     
     
     
139. PAIS SA , Nathwani RA, Dhar V, Nowain A, et al
     Effect of frequent dosing of an oral proton pump inhibitor on intragastric pH.
     Aliment Pharmacol Ther. 2006;23:1607-13.
     PubMed     Related articles    Abstract available
     
     
     
140. KLOK RM , Boersma C, Oosterhuis I, Visser ST, et al
     Switch patterns before and after patent expiry of omeprazole: a case study in The Netherlands.
     Aliment Pharmacol Ther. 2006;23:1595-600.
     PubMed     Related articles    Abstract available
     
     
     
141. POST PN , Kuipers EJ, Meijer GA
     Declining incidence of peptic ulcer but not of its complications: a nation-wide study in The Netherlands.
     Aliment Pharmacol Ther. 2006;23:1587-93.
     PubMed     Related articles    Abstract available
     
     
     
142. PEHL C , Wendl B, Pfeiffer A
     White wine and beer induce gastro-oesophageal reflux in patients with reflux disease.
     Aliment Pharmacol Ther. 2006;23:1581-6.
     PubMed     Related articles    Abstract available
     
     
     
143. KATZ PO , Scheiman JM, Barkun AN
     Review article: acid-related disease--what are the unmet clinical needs?
     Aliment Pharmacol Ther. 2006;23 Suppl 2:9-22.
     PubMed     Related articles    Abstract available
     
     
     May 2006
144. GOLDSTEIN JL , Lowry SC, Lanza FL, Schwartz HI, et al
     The impact of low-dose aspirin on endoscopic gastric and duodenal ulcer rates in users of a non-selective non-steroidal anti-inflammatory drug or a cyclo-oxygenase-2-selective inhibitor.
     Aliment Pharmacol Ther. 2006;23:1489-98.
     PubMed     Related articles    Abstract available
     
     
     
145. GUNARATNAM NT , Jessup TP, Inadomi J, Lascewski DP, et al
     Sub-optimal proton pump inhibitor dosing is prevalent in patients with poorly controlled gastro-oesophageal reflux disease.
     Aliment Pharmacol Ther. 2006;23:1473-7.
     PubMed     Related articles    Abstract available
     
     
     
146. CAMERON EA , Bell GD, Baldwin L, Powell KU, et al
     Long-term study of re-infection following successful eradication of Helicobacter pylori infection.
     Aliment Pharmacol Ther. 2006;23:1355-8.
     PubMed     Related articles    Abstract available
     
     
     
147. WONG CH , Chua CJ, Liam CK, Goh KL, et al
     Gastro-oesophageal reflux disease in 'difficult-to-control' asthma: prevalence and response to treatment with acid suppressive therapy.
     Aliment Pharmacol Ther. 2006;23:1321-7.
     PubMed     Related articles    Abstract available
     
     
     April 2006
148. YUAN Y , Thabane L, Hunt RH
     Levofloxacin-based rescue regimens after Helicobacter pylori treatment failure: how strong is the evidence?
     Aliment Pharmacol Ther. 2006;23:1283-5.
     PubMed     Related articles   
     
     
     
149. FASS R , Shapiro M
     Proton pump inhibitor failure in gastro-oesophagel reflux disease - what about eosinophilic oesophagitis? Authors' reply.
     Aliment Pharmacol Ther. 2006;23:1282-3.
     PubMed     Related articles   
     
     
     
150. SGOUROS SN , Mantides A
     Proton pump inhibitor failure in gastro-oesophageal reflux disease - what about eosinophilic oesophagitis?
     Aliment Pharmacol Ther. 2006;23:1281.
     PubMed     Related articles   
     
     
     
151. DI MARIO F , Aragona G, Dal Bo N, Cavallaro L, et al
     Bovine lactoferrin for Helicobacter pylori eradication: an open, randomized, multicentre study.
     Aliment Pharmacol Ther. 2006;23:1235-40.
     PubMed     Related articles    Abstract available
     
     
     
152. VENERITO M , Treiber G, Wex T, Kuester D, et al
     Effects of low-dose aspirin on gastric erosions, cyclooxygenase expression and mucosal prostaglandin-E do not depend on Helicobacter pylori infection.
     Aliment Pharmacol Ther. 2006;23:1225-33.
     PubMed     Related articles    Abstract available
     
     
     
153. MCMAHON BJ , Bruce MG, Hennessy TW, Bruden DL, et al
     Reinfection after successful eradication of Helicobacter pylori: a 2-year prospective study in Alaska Natives.
     Aliment Pharmacol Ther. 2006;23:1215-23.
     PubMed     Related articles    Abstract available
     
     
     
154. GOLDSTEIN JL , Miner PB Jr, Schlesinger PK, Liu S, et al
     Intragastric acid control in non-steroidal anti-inflammatory drug users: comparison of esomeprazole, lansoprazole and pantoprazole.
     Aliment Pharmacol Ther. 2006;23:1189-96.
     PubMed     Related articles    Abstract available
     
     
     
155. GOTTELAND M , Brunser O, Cruchet S
     Systematic review: are probiotics useful in controlling gastric colonization by Helicobacter pylori?
     Aliment Pharmacol Ther. 2006;23:1077-86.
     PubMed     Related articles    Abstract available
     
     
     
156. TRIADAFILOPOULOS G , Kaur B, Sood S, Traxler B, et al
     The effects of esomeprazole combined with aspirin or rofecoxib on prostaglandin E production in patients with Barrett's oesophagus.
     Aliment Pharmacol Ther. 2006;23:997-1005.
     PubMed     Related articles    Abstract available
     
     
     
157. METZ DC , Amer F, Hunt B, Vakily M, et al
     Lansoprazole regimens that sustain intragastric pH >6.0: an evaluation of intermittent oral and continuous intravenous infusion dosages.
     Aliment Pharmacol Ther. 2006;23:985-95.
     PubMed     Related articles    Abstract available
     
     
     
158. HOWDEN CW , Metz DC, Hunt B, Vakily M, et al
     Dose-response evaluation of the antisecretory effect of continuous infusion intravenous lansoprazole regimens over 48 h.
     Aliment Pharmacol Ther. 2006;23:975-84.
     PubMed     Related articles    Abstract available
     
     
     
159. GISBERT JP
     Levofloxacin-based rescue regimens after Helicobacter pylori treatment failure: how strong is the evidence? Author's reply.
     Aliment Pharmacol Ther. 2006;23:1285-1286.
     PubMed     Related articles   
     
     
     March 2006
160. COOPER BT , Chapman W, Neumann CS, Gearty JC, et al
     Continuous treatment of Barrett's oesophagus patients with proton pump inhibitors up to 13 years: observations on regression and cancer incidence.
     Aliment Pharmacol Ther. 2006;23:727-33.
     PubMed     Related articles    Abstract available
     
     
     
161. GISBERT JP , Luna M, Gomez B, Herrerias JM, et al
     Recurrence of Helicobacter pylori infection after several eradication therapies: long-term follow-up of 1000 patients.
     Aliment Pharmacol Ther. 2006;23:713-9.
     PubMed     Related articles    Abstract available
     
     
     
162. EMERENZIANI S , Habib FI, Ribolsi M, Caviglia R, et al
     Effect of hiatal hernia on proximal oesophageal acid clearance in gastro-oesophageal reflux disease patients.
     Aliment Pharmacol Ther. 2006;23:751-7.
     PubMed     Related articles    Abstract available
     
     
     
163. MALFERTHEINER P , Fass R, Quigley EM, Modlin IM, et al
     Review article: From gastrin to gastro-oesophageal reflux disease - a century of acid suppression.
     Aliment Pharmacol Ther. 2006;23:683-90.
     PubMed     Related articles    Abstract available
     
     
     
164. CHEY WD , Eswaren S, Howden CW, Inadomi JM, et al
     Primary care physician perceptions of non-steroidal anti-inflammatory drug and aspirin-associated toxicity: results of a national survey.
     Aliment Pharmacol Ther. 2006;23:655-68.
     PubMed     Related articles    Abstract available
     
     
     
165. VELDHUYZEN VAN ZANTEN SJ , Thomson AB, Barkun AN, Armstrong D, et al
     The prevalence of Barrett's oesophagus in a cohort of 1040 Canadian primary care patients with uninvestigated dyspepsia undergoing prompt endoscopy.
     Aliment Pharmacol Ther. 2006;23:595-9.
     PubMed     Related articles    Abstract available
     
     
     
166. DEVAULT KR
     Review article: the role of acid suppression in patients with non-erosive reflux disease or functional heartburn.
     Aliment Pharmacol Ther. 2006;23 Suppl 1:33-9.
     PubMed     Related articles    Abstract available
     
     
     February 2006
167. TAHA AS , Angerson WJ, Knill-Jones RP, Blatchford O, et al
     Upper gastrointestinal mucosal abnormalities and blood loss complicating low-dose aspirin and antithrombotic therapy.
     Aliment Pharmacol Ther. 2006;23:489-95.
     PubMed     Related articles    Abstract available
     
     

Thank you for your interest in scientific medicine.

Amedeo is a Bernd Sebastian Kamps website.    Design: